Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 22691211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: The systematic investigation of gastrointestinal diseases in China (SILC)

  2011cited by this paper
• The Pathogenesis of Systemic Sclerosis Revisited

  2011cited by this paper
• Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study.

  2011cited by this paper
• Expert Agreement on EULAR/EUSTAR Recommendations for the Management of Systemic Sclerosis

  2011cited by this paper
• Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases.

  2011cited by this paper
• Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.

  2011cited by this paper
• Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.

  2010cited by this paper
• Scleroderma: from pathophysiology to novel therapeutic approaches

  2010cited by this paper
• Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care Survey

  2010cited by this paper
• Gastroesophageal Reflux and Asthma in Children: A Systematic Review

  2010cited by this paper
• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  2010influential reference
• Does esophageal dysfunction affect the course of treadmill stress test in patients with recurrent angina-like chest pain?

  2010cited by this paper
• The influence of gastroesophageal reflux in the lung: A case–control study

  2010cited by this paper
• Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.

  2010cited by this paper
• Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.

  2009cited by this paper
• Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis?

  2009cited by this paper
• Scoring of reflux symptoms associated with scleroderma and the usefulness of rabeprazole.

  2009cited by this paper
• Scleroderma.

  2009cited by this paper
• Systemic sclerosis at the cellular level: molecular pathways of pathogenesis and its implication on future drug design.

  2009cited by this paper
• Esophageal manometry in 28 systemic sclerosis Brazilian patients: findings and correlations.

  2009cited by this paper
• High prevalence of gastroesophageal reflux in patients with clinical unstable angina and known coronary artery disease

  2008cited by this paper
• Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.

  2008cited by this paper
• Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.

  2008cited by this paper
• Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature.

  2008cited by this paper
• Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.

  2008influential reference
• Skin involvement in systemic sclerosis.

  2008cited by this paper
• Gastrointestinal Manifestations of Systemic Sclerosis

  2008cited by this paper
• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

  2007influential reference
• Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.

  2007cited by this paper
• Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.

  2007cited by this paper
• Changes in causes of death in systemic sclerosis, 1972–2002

  2007cited by this paper
• A case–control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)

  2006cited by this paper
• Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.

  2006influential reference
• Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.

  2006cited by this paper
• Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy

  2006cited by this paper
• Undifferentiated connective tissue diseases (UCTD).

  2006cited by this paper
• The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

  2006influential reference
• Oesophageal manometry in early and definite systemic sclerosis

  2005cited by this paper
• Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.

  2004influential reference
• Criteria for the classification of early systemic sclerosis.

  2001cited by this paper
• Gastric involvement in systemic sclerosis: a prospective study

  2001cited by this paper
• Oesophageal manometry and video-radiology in patients with systemic sclerosis: a retrospective study of its clinical value.

  2000cited by this paper
• Cardioesophageal reflexes: an invasive human study.

  1998cited by this paper
• Systemic sclerosis in men: clinical and immunological differences.

  1996cited by this paper
• Gastrointestinal features of scleroderma.

  1996cited by this paper
• SYSTEMIC SCLEROSIS : A Vascular Perspective

  1996cited by this paper
• Gastrointestinal manifestations of systemic sclerosis.

  1994cited by this paper
• Esophageal contribution to chest pain in patients with coronary artery disease.

  1990cited by this paper
• The gastrointestinal manifestations of scleroderma: pathogenesis and management.

  1980cited by this paper
• Evidence-based Clinical Practice Guidelines : Accp * Pulmonary Arterial Hypertension Screening, Early Detection, and Diagnosis Of

  year unknowncited by this paper

• Reliability and validity of the Korean version of the University of California–Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis

  2021cites this paper
• Esclerosis sistémica y participación gastrointestinal

  2020cites this paper
• Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease

  2020cites this paper
• Systemic sclerosis and gastrointestinal involvement

  2020cites this paper
• Gastro-intestinal Involvement in Systemic Sclerosis

  2017cites this paper
• Which diseases are risk factors for developing gastroesophageal reflux disease?

  2017cites this paper
• IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.

  2016cites this paper
• Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases.

  2014cites this paper
• GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis.

  2014cites this paper
• Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China.

  2014cites this paper
• Clinical characteristics of systemic sclerosis patients with digital ulcers in China.

  2013cites this paper
• Systemic sclerosis: a critical digest of the recent literature.

  2013cites this paper